SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-22-101009
Filing Date
2022-04-11
Accepted
2022-04-11 08:36:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFC14A d340906ddefc14a.htm DEFC14A 226519
2 GRAPHIC g340906g13n17.jpg GRAPHIC 30764
3 GRAPHIC g340906g13n24.jpg GRAPHIC 36201
4 GRAPHIC g340906g13n25.jpg GRAPHIC 38357
  Complete submission text file 0001193125-22-101009.txt   359802
Mailing Address
Business Address
KAYNE RICHARD A (Filed by) CIK: 0000884413 (see all company filings)

Type: DEFC14A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-39503 | Film No.: 22818546
SIC: 2836 Biological Products, (No Diagnostic Substances)